Member Info for iaintgotaclu

Thanks managed to get some at 1.6089 only £900

What happening here then? troajan

its a coming mega rise

and if it hits would you bounce back up? and if so to where

buyers back MMs had some buy orders to fill this will do 100% today i feel once orders filled

buying op coming up if your quick and can get some

a few sells ready for the next leg up as the MMs aint got none so looking good

can you buy? only 5 mill shares here most tightly held

ticked up on a sell

+40%

NO STOCK AT ALL

I am pleased to report that the Company's cash position has increased since the financial year end and anticipate that the Company should be cash flow positive during the current financial year 2015/2016.

CHAIRMAN'S STATEMENT I am pleased to report that in the financial year to 31 March 2015 we experienced an improvement in the business with revenues and other income more than doubling from $419,000 to $857,000. The administrative expenses in operating the business before the costs of the litigation fell from $859,000 to $776,000, resulting in a net profit before exceptional items and IP amortisation of $81,000. Exceptional costs relating to the litigation against Frank Maguire and related parties amounted to $204,000 which compares to the cost incurred at the 6-month stage of $212,000, the reduction in the second half of the year being a further recovery from our insurers net of the excess on the insurance policy payable by AorTech. Over the course of the year, the cash position fell from $642,000 to $360,000. At the interim stage however, the cash position stood at $335,000 and there has therefore been progress during the second half.

+36% RNS Number : 3738V AorTech International PLC 07 August 2015 AorTech International plc ("AorTech", "the Company" or "the Group") Audited results for the year ended 31 March 2015 AorTech International plc (AIM: AOR), the biomaterials and medical device IP company, today announces its results for the year ended 31 March 2015. Financial summary -- Group revenue from continuing operations doubled from previous year to US$844k -- Operating profit of US$81k (2014: US$440k loss) before amortisation costs and exceptional items -- Loss from continuing operations more than halved from US$823k to US$326k Other developments -- Continuing reduction in administrative expenses, following completion of exit from US -- Consideration being given to capitalising on existing IP and experience of past development work to create Polymer Heart Valves -- Share Capital reorganisation proposed

+30%

after all these dumps they will still take all mine and its not going to NT strange that

how can it be a pump and dump when none of the trades brought today have sold Massey you clown

Some people just cannot see the wood thru the treees

wrong spread actually 3.62 to sell

what do you know UKMASSEY